Loading clinical trials...
Loading clinical trials...
This is a phase 1 multiple ascending dose (MAD) study, conducted in subjects with Type 1 and Type 2 diabetes mellitus
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hanmi Pharmaceutical Company Limited
NCT03648918 · Type1diabetes, Diabetes Mellitus, Type 1, and more
NCT06961019 · Type2 Diabetes Mellitus
NCT05777330 · Type1 Diabetes Mellitus
NCT03811470 · Type 2 Diabetes Mellitus, Type1 Diabetes Mellitus, and more
NCT03851627 · Fatty Liver, Overweight/Obesity, and more
Hanmi Investigative Site
Chula Vista, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions